Search results
4 wrz 2024 · New Benchmark for Targeted Therapies in Lung Cancer: Median Progression-Free Survival for Lorlatinib in Advanced ALK+ Non–Small Cell Lung Cancer Surpasses 5 years. JCO 42 , 3383-3386 (2024). DOI: 10.1200/JCO.24.01147
15 lut 2021 · Our contemporary study provides lung cancer clinical trial including interventional and observational examinations. Different qualities of preliminaries, for example, design, location, type of intervention, patient enrolment and sponsors are discussed.
7 kwi 2021 · We apply Trial Pathfinder to emulate completed trials of advanced non-small-cell lung cancer using data from a nationwide database of electronic health records comprising 61,094...
7 wrz 2022 · Clinical trials investigate every aspect of lung cancer care, including: Prevention trials explore new ways to prevent lung cancer from developing in people who have never had the disease or recurring (returning) in those who have. Screening trials develop and test new ways to detect lung cancer.
CENTRAL is a rich database of bibliographic reports of randomized controlled trials. You can search CENTRAL for high-quality evidence from many trusted sources. This helps you find the best available evidence to answer your questions quicker.
3 dni temu · Table 1 Patient characteristics for all advanced non-small cell lung cancer patients treated with 1 L pembrolizumab mono- or combination therapy in Norway (real-world) or clinical trials (Keynote ...
11 sie 2023 · Metrics. Abstract. Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last decade, significant advancements in the diagnosis and treatment of lung cancer, particularly NSCLC, have been achieved with the help of molecular translational research.
